Therapy Areas: Allergy
13 June 2019 - - German biotechnology company Sirion Biotech GmbH has entered into a license agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of th...
13 June 2019 - - US-based biopharmaceutical company Aimmune Therapeutics, Inc. (NASDAQ: AIMT) held a presentation at the Institute for Clinical and Economic Review's Public Meeting reviewing the ...
10 June 2019 - ALK Abello A/S (ALK)(CPH:ALKB), a specialty pharmaceutical company focused on allergy and allergic asthma, announced on Friday the successful completion of the marketing authorisation p...
4 June 2019 - - US-based biopharmaceutical company Aimmune Therapeutics, Inc. (NASDAQ: AIMT) has presented topline results from the pivotal European Phase 3 ARTEMIS clinical trial, which it previously...
31 May 2019 - - US-based biotechnology company Axial Biotherapeutics is highlighting the publication of new findings in Cell by Sarkis K. Mazmanian, Ph.D., the company's scientific co-f...
31 May 2019 - Biotechnology company Ridgeback Biotherapeutics LP reported on Thursday the receipt of the US Food and Drug Administration's (FDA) orphan drug designation for the experimental mAb11...
Related Headlines